Periacetabular Osteotomy for Developmental Dysplasia of the Hip and Femoroacetabular Impingement: A Study Using the U.K. Non-Arthroplasty Hip Registry (NAHR) Data Set.


Journal

The Journal of bone and joint surgery. American volume
ISSN: 1535-1386
Titre abrégé: J Bone Joint Surg Am
Pays: United States
ID NLM: 0014030

Informations de publication

Date de publication:
05 Aug 2020
Historique:
entrez: 10 8 2020
pubmed: 10 8 2020
medline: 20 2 2021
Statut: ppublish

Résumé

Periacetabular osteotomy (PAO) is a well-recognized procedure for the treatment of hip dysplasia in young adults and can be used for the surgical management of femoroacetabular impingement (FAI) with acetabular retroversion. The aim of this study was to use a national database to assess the outcomes of PAO for developmental dysplasia of the hip (DDH) and for FAI. All patients in whom an isolated PAO had been performed between January 2012 and February 2019 were identified in the Non-Arthroplasty Hip Registry (NAHR). Their outcomes were assessed using the EuroQol-5 Dimensions (EQ-5D) index and the International Hip Outcome Tool (iHOT)-12 preoperatively and then at 6 months, 12 months, and 2 years postoperatively. Six hundred and thirty (630) PAOs were identified, with 558 (89%) performed for DDH and 72 (11%) performed for FAI. Most patients (90%) were female. The mean age in the DDH group (31.2 years) was significantly higher (p < 0.0001) than that in the FAI group (26.5 years). There were no other significant between-group demographic differences. Preoperatively and at each follow-up time-period, iHOT-12 scores were better in the DDH group than in the FAI group; however, only the preoperative scores differed significantly. There was significant improvement between the preoperative and 6-month iHOT-12 and EQ-5D index scores in both the DDH and the FAI group. This improvement was maintained at 12 months postoperatively, by which time almost 90% of the patients had achieved the minimum clinically important difference (MCID) in their iHOT-12 score. This study shows that PAO is a successful surgical intervention for DDH and FAI in the short term, with significant improvement in patient-reported outcome scores that is maintained up to 2 years postoperatively. Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Sections du résumé

BACKGROUND BACKGROUND
Periacetabular osteotomy (PAO) is a well-recognized procedure for the treatment of hip dysplasia in young adults and can be used for the surgical management of femoroacetabular impingement (FAI) with acetabular retroversion. The aim of this study was to use a national database to assess the outcomes of PAO for developmental dysplasia of the hip (DDH) and for FAI.
METHODS METHODS
All patients in whom an isolated PAO had been performed between January 2012 and February 2019 were identified in the Non-Arthroplasty Hip Registry (NAHR). Their outcomes were assessed using the EuroQol-5 Dimensions (EQ-5D) index and the International Hip Outcome Tool (iHOT)-12 preoperatively and then at 6 months, 12 months, and 2 years postoperatively.
RESULTS RESULTS
Six hundred and thirty (630) PAOs were identified, with 558 (89%) performed for DDH and 72 (11%) performed for FAI. Most patients (90%) were female. The mean age in the DDH group (31.2 years) was significantly higher (p < 0.0001) than that in the FAI group (26.5 years). There were no other significant between-group demographic differences. Preoperatively and at each follow-up time-period, iHOT-12 scores were better in the DDH group than in the FAI group; however, only the preoperative scores differed significantly. There was significant improvement between the preoperative and 6-month iHOT-12 and EQ-5D index scores in both the DDH and the FAI group. This improvement was maintained at 12 months postoperatively, by which time almost 90% of the patients had achieved the minimum clinically important difference (MCID) in their iHOT-12 score.
CONCLUSIONS CONCLUSIONS
This study shows that PAO is a successful surgical intervention for DDH and FAI in the short term, with significant improvement in patient-reported outcome scores that is maintained up to 2 years postoperatively.
LEVEL OF EVIDENCE METHODS
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Identifiants

pubmed: 32769597
doi: 10.2106/JBJS.18.01387
pii: 00004623-202008050-00008
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1312-1320

Références

Millis MB, Murphy SB, Poss R. Osteotomies about the hip for the prevention and treatment of osteoarthrosis. Instr Course Lect. 1996;45:209-26.
Lack W, Windhager R, Kutschera HP, Engel A. Chiari pelvic osteotomy for osteoarthritis secondary to hip dysplasia. Indications and long-term results. J Bone Joint Surg Br. 1991 Mar;73(2):229-34.
Murphy SB, Ganz R, Müller ME. The prognosis in untreated dysplasia of the hip. A study of radiographic factors that predict the outcome. J Bone Joint Surg Am. 1995 Jul;77(7):985-9.
Vanden Berg-Foels WS, Schwager SJ, Todhunter RJ, Reeves AP. Femoral head shape differences during development may identify hips at risk of degeneration. Ann Biomed Eng. 2011 Dec;39(12):2955-63. Epub 2011 Sep 10.
Steppacher SD, Tannast M, Ganz R, Siebenrock KA. Mean 20-year followup of Bernese periacetabular osteotomy. Clin Orthop Relat Res. 2008 Jul;466(7):1633-44. Epub 2008 May 1.
Ganz R, Klaue K, Vinh TS, Mast JW. A new periacetabular osteotomy for the treatment of hip dysplasias. Technique and preliminary results. Clin Orthop Relat Res. 1988 Jul;232:26-36.
Wylie JD, Kapron AL, Peters CL, Aoki SK, Maak TG. Relationship between the lateral center-edge angle and 3-dimensional acetabular coverage. Orthop J Sports Med. 2017 Apr 12;5(4):2325967117700589.
Kraeutler MJ, Garabekyan T, Pascual-Garrido C, Mei-Dan O. Hip instability: a review of hip dysplasia and other contributing factors. Muscles Ligaments Tendons J. 2016 Dec 21;6(3):343-53.
Mast JW, Brunner RL, Zebrack J. Recognizing acetabular version in the radiographic presentation of hip dysplasia. Clin Orthop Relat Res. 2004 Jan;418:48-53.
Banerjee P, McLean CR. Femoroacetabular impingement: a review of diagnosis and management. Curr Rev Musculoskelet Med. 2011 Mar 16;4(1):23-32.
Reynolds D, Lucas J, Klaue K. Retroversion of the acetabulum. A cause of hip pain. J Bone Joint Surg Br. 1999 Mar;81(2):281-8.
Sabetta E, Scaravella E. Treatment of pincer-type femoroacetabular impingement. Joints. 2015 Nov 3;3(2):78-81.
Jørgensen RW, Dippmann C, Dahl L, Stürup J. Treatment algorithm for patients with non-arthritic hip pain, suspect for an intraarticular pathology. Open Orthop J. 2016 Aug 19;10:404-11.
Parry JA, Swann RP, Erickson JA, Peters CL, Trousdale RT, Sierra RJ. Midterm outcomes of reverse (anteverting) periacetabular osteotomy in patients with hip impingement secondary to acetabular retroversion. Am J Sports Med. 2016 Mar;44(3):672-6.
Pun S, Merz M, Bowen G, Hingsammer A, Yen Y, Kim YJ, Millis MB. Periacetabular osteotomy to uncover the hip: uncommon variations on a common procedure. J Hip Preserv Surg. 2016 Sep 3;3(Suppl 1):hnw030.032.
Thawrani DP, Feldman DS, Sala DA. Not all hip dysplasias are the same: preoperative CT version study and the need for reverse Bernese periacetabular osteotomy. J Pediatr Orthop. 2017 Jan;37(1):47-52.
Zurmühle CA, Anwander H, Albers CE, Hanke MS, Steppacher SD, Siebenrock KA, Tannast M. Periacetabular osteotomy provides higher survivorship than rim trimming for acetabular retroversion. Clin Orthop Relat Res. 2017 Apr;475(4):1138-50. Epub 2016 Dec 5.
Fader RR, Tao MA, Gaudiani MA, Turk R, Nwachukwu BU, Esposito CI, Ranawat AS. The role of lumbar lordosis and pelvic sagittal balance in femoroacetabular impingement. Bone Joint J. 2018 Oct;100-B(10):1275-9.
Griffin DR, Parsons N, Mohtadi NG, Safran MR; Multicenter Arthroscopy of the Hip Outcomes Research Network. A short version of the International Hip Outcome Tool (iHOT-12) for use in routine clinical practice. Arthroscopy. 2012 May;28(5):611-6; quiz 616-8.
Jónasson P, Baranto A, Karlsson J, Swärd L, Sansone M, Thomeé C, Ahldén M, Thomeé R. A standardised outcome measure of pain, symptoms and physical function in patients with hip and groin disability due to femoro-acetabular impingement: cross-cultural adaptation and validation of the international Hip Outcome Tool (iHOT12) in Swedish. Knee Surg Sports Traumatol Arthrosc. 2014 Apr;22(4):826-34. Epub 2013 Oct 18.
Sochacki KR, Jack RA 2nd, Safran MR, Nho SJ, Harris JD. There is a significant discrepancy between “big data” database and original research publications on hip arthroscopy outcomes: a systematic review. Arthroscopy. 2018 Jun;34(6):1998-2004. Epub 2018 Feb 21.
Byrd JW, Jones KS. Arthroscopic management of femoroacetabular impingement in athletes. Am J Sports Med. 2011 Jul;39(Suppl):7S-13S.
Beaulé PE, Le Duff MJ, Zaragoza E. Quality of life following femoral head-neck osteochondroplasty for femoroacetabular impingement. J Bone Joint Surg Am. 2007 Apr;89(4):773-9.
Peters CL, Anderson LA, Erickson JA, Anderson AE, Weiss JA. An algorithmic approach to surgical decision making in acetabular retroversion. Orthopedics. 2011 Jan 3;34(1):10.
Ganz R, Gill TJ, Gautier E, Ganz K, Krügel N, Berlemann U. Surgical dislocation of the adult hip a technique with full access to the femoral head and acetabulum without the risk of avascular necrosis. J Bone Joint Surg Br. 2001 Nov;83(8):1119-24.
Murphy S, Tannast M, Kim YJ, Buly R, Millis MB. Debridement of the adult hip for femoroacetabular impingement: indications and preliminary clinical results. Clin Orthop Relat Res. 2004 Dec;429:178-81.
Peters CL, Erickson JA. Treatment of femoro-acetabular impingement with surgical dislocation and débridement in young adults. J Bone Joint Surg Am. 2006 Aug;88(8):1735-41.
McCarthy JC, Jarrett BT, Ojeifo O, Lee JA, Bragdon CR. What factors influence long-term survivorship after hip arthroscopy? Clin Orthop Relat Res. 2011 Feb;469(2):362-71.
Comba F, Yacuzzi C, Ali PJ, Zanotti G, Buttaro M, Piccaluga F. Joint preservation after hip arthroscopy in patients with FAI. Prospective analysis with a minimum follow-up of seven years. Muscles Ligaments Tendons J. 2016 Dec 21;6(3):317-23.
Byrd JW, Jones KS. Arthroscopic management of femoroacetabular impingement: minimum 2-year follow-up. Arthroscopy. 2011 Oct;27(10):1379-88. Epub 2011 Aug 20.
Menge TJ, Briggs KK, Dornan GJ, McNamara SC, Philippon MJ. Survivorship and outcomes 10 years following hip arthroscopy for femoroacetabular impingement: labral debridement compared with labral repair. J Bone Joint Surg Am. 2017 Jun 21;99(12):997-1004.
Philippon MJ, Schroder E, Souza BG, Briggs KK. Hip arthroscopy for femoroacetabular impingement in patients aged 50 years or older. Arthroscopy. 2012 Jan;28(1):59-65. Epub 2011 Oct 7.
Horisberger M, Brunner A, Herzog RF. Arthroscopic treatment of femoral acetabular impingement in patients with preoperative generalized degenerative changes. Arthroscopy. 2010 May;26(5):623-9. Epub 2010 Feb 11.
Laude F, Sariali E, Nogier A. Femoroacetabular impingement treatment using arthroscopy and anterior approach. Clin Orthop Relat Res. 2009 Mar;467(3):747-52. Epub 2008 Dec 16.
Clohisy JC, McClure JT. Treatment of anterior femoroacetabular impingement with combined hip arthroscopy and limited anterior decompression. Iowa Orthop J. 2005;25:164-71.
Srinivasan SC, Hosny HA, Williams MR. Combined hip arthroscopy and limited open osteochondroplasty for anterior femoroacetabular impingement: early patient reported outcomes. Hip Int. 2013 Mar-Apr;23(2):218-24. Epub 2013 Feb 11.
Siebenrock KA, Schoeniger R, Ganz R. Anterior femoro-acetabular impingement due to acetabular retroversion. Treatment with periacetabular osteotomy. J Bone Joint Surg Am. 2003 Feb;85(2):278-86.
Siebenrock KA, Schaller C, Tannast M, Keel M, Büchler L. Anteverting periacetabular osteotomy for symptomatic acetabular retroversion: results at ten years. J Bone Joint Surg Am. 2014 Nov 5;96(21):1785-92.
Belzile EL, Beaulé PE, Ryu JJ, Clohisy JC; Academic Network of Conservation Hip Outcome Research (ANCHOR) Members. Outcomes of joint preservation surgery: comparison of patients with developmental dysplasia of the hip and femoroacetabular impingement. J Hip Preserv Surg. 2016 Nov 10;3(4):270-7.

Auteurs

Richard Holleyman (R)

Health Education North East England, Newcastle upon Tyne, England.
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, England.

Mark Andrew Sohatee (MA)

Health Education North East England, Newcastle upon Tyne, England.

Johan Witt (J)

University College London Hospitals NHS Foundation Trust, London, England.

Marcus J K Bankes (MJK)

Guy's and St Thomas' NHS Foundation Trust, London, England.

Tony J Andrade (TJ)

Royal Berkshire NHS Foundation Trust, Reading, England.

Tim Board (T)

Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, England.

Jonathan Lee Conroy (J)

Harrogate and District NHS Foundation Trust, Harrogate, England.

Matthew Wilson (M)

Royal Devon and Exeter NHS Foundation Trust, Exeter, England.

Callum McBryde (C)

The Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, England.

Vikas Khanduja (V)

Addenbrooke's Hospital-The Cambridge University Hospitals NHS Foundation Trust, Cambridge, England.

Ajay Malviya (A)

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, England.
Northumbria NHS Foundation Trust, Newcastle upon Tyne, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH